Literature DB >> 11558490

Impaired fatty acid oxidation in propofol infusion syndrome.

A Wolf, P Weir, P Segar, J Stone, J Shield.   

Abstract

Propofol infusion syndrome is a rare but frequently fatal complication in critically ill children given long-term propofol infusions. We describe a child who developed all the clinical features of propofol infusion syndrome and was treated successfully with haemofiltration. Biochemical analysis before haemofiltration showed a large rise in plasma concentrations of malonylcarnitine (3.3 micromol/L) and C5-acylcarnitine (8.4 micromol/L), which returned to normal after recovery. Abnormalities are consistent with specific disruption of fatty-acid oxidation caused by impaired entry of long-chain acylcarnitine esters into the mitochondria and failure of the mitochondrial respiratory chain at complex 11.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11558490     DOI: 10.1016/S0140-6736(00)04064-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  65 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Lactic acidosis: an early marker of propofol infusion syndrome?

Authors:  Marc Koch; Daniel De Backer; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

3.  [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy].

Authors:  A Haas; F Wappler
Journal:  Anaesthesist       Date:  2015-08-28       Impact factor: 1.041

4.  Propofol: contraindicated for sedation of pediatric intensive care patients.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

5.  The syndrome of irreversible acidosis after prolonged propofol infusion.

Authors:  Monisha A Kumar; Victor C Urrutia; Carole E Thomas; Karine J Abou-Khaled; Robert J Schwartzman
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Propofol-related infusion syndrome heralding a mitochondrial disease: case report.

Authors:  Martin Savard; Nicolas Dupré; Alexis F Turgeon; Richard Desbiens; Stephan Langevin; Denis Brunet
Journal:  Neurology       Date:  2013-07-19       Impact factor: 9.910

Review 7.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

8.  Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity.

Authors:  Christian Bergamini; Noah Moruzzi; Francesco Volta; Laura Faccioli; Jantje Gerdes; Maria Cristina Mondardini; Romana Fato
Journal:  J Bioenerg Biomembr       Date:  2016-08-15       Impact factor: 2.945

9.  Propofol infusion syndrome heralded by ECG changes.

Authors:  Elsbeth J Mijzen; Bram Jacobs; Adnan Aslan; Michael G G Rodgers
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 10.  Anesthetic considerations in patients with mitochondrial defects.

Authors:  Julie Niezgoda; Phil G Morgan
Journal:  Paediatr Anaesth       Date:  2013-03-28       Impact factor: 2.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.